OTCMKTS:ATTBF

Abattis Bioceuticals - ATTBF Stock Forecast, Price & News

Add

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: 11,650 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Abattis Bioceuticals (OTCMKTS:ATTBF) Stock

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

Receive ATTBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abattis Bioceuticals and its competitors with MarketBeat's FREE daily newsletter.

ATTBF Stock News Headlines

September 9, 2022 | morningstar.com

Abattis Bioceuticals Corp ATTBF Sustainability

March 27, 2022 | benzinga.com

When Will New Jersey's Marijuana Sales Begin? What's Next After Yet Another Delay?

March 25, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Missile" to Replace Nuclear Missiles

CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!

March 26, 2022 | benzinga.com

Cannabis Payments Co Launches Women In Finance & Technology Scholarship

March 25, 2022 | benzinga.com

Charlotte's Web Q4 Revenue Up 5% QoQ, Adjusted EBITDA Loss Improves By $5M

March 20, 2022 | benzinga.com

Federal Marijuana Cases Drop Again In 2021 As More States Legalize

March 20, 2022 | benzinga.com

Schwazze Common Shares Will Trade On NEO Exchange Under Symbol 'SHWZ' In Late March

March 9, 2022 | benzinga.com

MDXclusive Launches Lab-Tested Topical And Sublingual CBD Products

March 25, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Missile" to Replace Nuclear Missiles

CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!

March 6, 2022 | benzinga.com

The Perfect CBD To THC Ratio? New Study Says 1 To 1 Is The Best Ratio For Therapeutic Effects

March 5, 2022 | benzinga.com

Most D.C. Workers To Avoid Pre-Employment Marijuana Testing Under New Bill

March 3, 2022 | benzinga.com

BDSA Report: Global Cannabis Sales Will Jump 22% In 2022, Grow To $61B By 2026

January 26, 2022 | benzinga.com

Trulieve Files Resale Registration With SEC For Subordinate Voting Shares Of 2021 Acquisitions

December 22, 2021 | benzinga.com

Latest Issue Of Psychedelics Mag DoubleBlind Plays With The Tension Between Old And New

October 18, 2021 | benzinga.com

Micah Tapman Of BDSA Lays Out Cannabis Data In The Northeast

September 3, 2021 | benzinga.com

Apple's Cannabis iPhone App Is Benefiting Businesses And Consumers, Where's Google Play Store?

August 31, 2021 | benzinga.com

Panama Is Close To Legalizing Medicinal Cannabis

August 18, 2021 | benzinga.com

EXCLUSIVE: Healthcare Attorney Brian Rath Discusses Medical Marijuana In Nursing Homes & Assisted Living, Legal? It's Complicated

June 22, 2021 | benzinga.com

Psychedelic Guides With Lucia Huang Of Osmind

March 19, 2021 | finance.yahoo.com

Abattis and Management Overcome Legal and Regulatory Allegations

December 24, 2020 | markets.businessinsider.com

News for Abattis Bioceuticals Corp

November 25, 2020 | benzinga.com

Maine's First Month Of Adult-Use Cannabis Sales Yields $1.4M

November 22, 2020 | benzinga.com

Psyched: German Government Funds Psilocybin Study, Field Trip Opens Psilocybin Clinic

November 9, 2020 | benzinga.com

Psyched: Oregon Legalizes Psilocybin, Washington DC Decriminalizes Psychedelics, Cybin And Entheon To Go Public

November 7, 2020 | benzinga.com

A Standard Dose For Cannabis: Pros And Cons

November 7, 2020 | benzinga.com

How To Connect With Your Distributed Workforce

September 11, 2020 | bloomberg.com

Abattis Enters into Agreement to Acquire Remaining Minority Interest in Gabriola Green Farms

See More Headlines

Receive ATTBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abattis Bioceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:ATTBF
CUSIP: N/A
CIK: N/A
Web: www.abattis.com
Phone: N/A
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Robert J. Abenante BBA (Age 40)
CA, MPAcc, Pres, CEO & Director
Comp: $277.01k

Mr. Douglas J. Sorocco LLB (Age 52)
Advisor
Comp: $91.08k

Mr. Guy P. Dancosse CIRC (Age 79)
CRIA, ICD.D, Q.C., Advisor
Comp: $107.52k

Mr. Francesco Paolini
CFO & Director

Mr. Patrick Mitchell
COO & Director

Mr. Shawn Balaghi
Head of Corp. Devel.

Mr. Clayton Chessa
Head of Operations

Mr. Jim Carter
Head of Mergers and Acquisitions Advisory

Mr. Christopher P. Cherry C.A. (Age 44)
CPA, CA, CGA, CPA, Corp. Comptroller

Ms. Nicole Breitinger
Corp. Sec.

Key Competitors

View All Competitors

ATTBF Stock - Frequently Asked Questions

What is Abattis Bioceuticals' stock symbol?: Abattis Bioceuticals trades on the OTCMKTS under the ticker symbol "ATTBF."
How do I buy shares of Abattis Bioceuticals?: Shares of ATTBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:ATTBF) was last updated on 3/25/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial